Science Director
Charles River, England, United Kingdom
Science Director at Charles River Labs where I oversee small molecule Early Discovery drug discovery projects particularly in the area of Huntington's Disease. Prior to joining CRL in 2016 I was a senior group leader at Takeda Cambridge with responsibility for assay development, in vitro pharmacology and hit ID activities. I'm a biologist by training with degree in Biochemistry from the University of Liverpool and PhD in Molecular Biology from the Institute of Cancer Research (ICR) London. My career in drug discovery started in a Wellcome Foundation funded lab at the ICR cloning novel kinase as potential breast cancer targets. Since then I've gained over 20 years drug discovery experience in academia, biotech, pharma and CRO environments and been a member of project teams that have been fortunate enough to transition small molecules to pre-clinical & clinical development.
Disclosure information not submitted.
Tuesday, February 8, 2022
10:00 AM – 10:30 AM